Journal of the American Chemical Society · 2017 · 70 citations · 31 references
PharmacyMicrobiologyPharmaceuticsDrug DeliveryNanobiotechnologyNanoparticle Drug DeliveryDrug Delivery EngineeringNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle DesignPathogen DetectionAntimicrobial Drug DeliveryAntimicrobial NanomedicineMesoporous Silica NanomaterialsMesoporous Silica Nanoparticle Co-deliveryMesoporous Silica NanoparticlesNanoparticle-based AntimicrobialsPathogen ReleaseSilica-based Nanoparticles
We present a synthetic approach to a highly pathogen-selective detection and delivery platform based on the interaction of an antibody nanovalve with a tetrasaccharide from the O-antigen of the lipopolysaccharide (LPS) of Francisella tularensis bacteria, a Tier 1 Select Agent of bioterrorism. Different design considerations are explored, and proof-of-concept for highly pathogen-specific cargo release from mesoporous silica nanoparticles is demonstrated by comparisons of the release of a signal transducer and model drug by LPS from F. tularensis vs Pseudomonas aeruginosa and by F. tularensis live bacteria vs the closely related bacterium Francisella novocida. In addition to the specific response to a biowarfare agent, treatment of infectious diseases in general could benefit tremendously from a delivery platform that releases its antibiotic payload only at the site of infection and only in the presence of the target pathogen, thereby minimizing off-target toxicities.
31
Biological warfare. A historical perspective
George W. Christopher · JAMA · 1997 · 526 citations
LTC George W. Christopher · JAMA · 1997 · 415 citations
Samuel Saslaw · Archives of Internal Medicine · 1961 · 406 citations